Novartis Investigative Site

Schiedam 3118 JH

1 studies enrolling now · 2 studies all time

What they study most

Metastatic Hormone-sensitive Prostate Cancer, Psoriatic Arthritis

Studies at this site

• An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) — Recruiting now
• Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis — Completed